Restenosis after percutaneous transluminal coronary angioplasty: Have we been aiming at the wrong target?  by Currier, Jesse W. & Faxon, David P.
516 JACC Vol. 25, No. 2 
February 1995516-20 
EDITORIAL REVIEW 
Restenosis After Percutaneous Trausluminal Coronary Augioplasty: 
Have We Been Aiming at the Wrong Target? 
JESSE W. CURRIER, MD, FACC, DAVID P. FAXON, MD, FACC 
Los Angeles, Califorth 
Restenosis after percutaneous coronary bailoon angioplasty 
remains a significant problem. Despite success with a variety of 
agents in animal models, no agent has proved clearly successful in 
reducing restenosis in humans. There are many potential reasons 
for this, but one possibility is that because of our incomplete 
understanding of the restenotic process, therapy has been directed 
at the wrong target. Arterial remodeling (changes in !otai vessel 
area or changes in area circumscribed by the internal elastic 
lamina) is well described in de novo atherosclerosis, am! there is 
increasing evidence that t;ris process occurs after angioplasty. 
Thus, restenosis can be thought of not merely as neointimal 
formation in response to balloon injury, but as arterial remodel- 
ing in response to balloon injury and neointimal formation. 
Arterial remodeling may consist of actual constriction of the 
-- 
Percutaneous transluminal coronary angioplasty has gained 
universal acceptance as a revascularization procedure despite 
important limitations. One of the major limitations is the 
chronic renarrowing of the dilated vessel in response to the 
balloon <or other interventional device) injury that typically 
occurs over 3 to 6 months ;;fter the procedure (1). The 
pathophysiology of rcstenosis is complex and incompletely 
understood. Early events in res:enosis are thought to consist of 
immediate elastic recoil, platelet deposition and thrombus 
formation, followed by smooth muscle cell proliferation and 
matrix formation (2). It has been suggested that restenosis is 
analogous to wound healing ~3)~ and the commonly accepted 
paradigm is a process of ncointimal hyperplasia in response to 
balloon injury (4,s). As understanding of the various compo- 
nents of this pathophysiologic paradigm has advanced over the 
past decade, attempts have been made to attack restenosis at 
many points along the process, with impressive success in 
multiple animal models. In collaboration with colleagues in 
molecular biology, newer, more potent agents have been 
utilized, particularly against platelet deposition (6) and smooth 
muscle cell proliferation (7). Despite >50 published major 
clinical trials randomizing >12,OOO patients and attempting to 
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artery, as has been described in some animal models and in 
preliminary fashion in humans, or of compensatory enlargement 
as has been described in de novo atherosclerosis and in the 
hypercholesterolemic rabbit iliac artery model. Arterial constric- 
tion can result in restenosis with minimal neointimal formation. 
Compensatory enlargement accommodates ignificant amounts o- 
neointimal formation, with preservation of lumen area despite an 
increase in neointimal area adequate to cause restenosis in a 
noncompensated artery. This expanded paradigm of arterial 
remodeling and intimal formation may in part account for the 
lack of success in clinical trials to date, and therapy directed at 
arterial remodeling as well as intimal formation may be required 
to reduce restenosis after coronary interventions. 
(J Am Co11 Curdial 1995;25:516-20) 
- _-- 
limit restenosis by pharmacologic means, there is no agent that 
has clearly been shown to be effective in humans (8). 
There are many potential reasons why the clinical trials 
have been negative (9). First, perhaps the process in humans is 
different from that occurring in currently available animal 
models. Second, many clinical trials (10,ll) have used agents 
shown to be effective in animal models (l&13), but often the 
positive effect in the animal model was achieved only at very 
high doses that would not be tolerated in humans. Some of the 
ciinical trials did not pretreat patients (14), even when the 
animal data suggested a much greater benefit with pretreat- 
ment (15). Finally, many clinical trials were cnderpowered to 
detect a significant difference, suffered from significant with- 
drawal bias, or had incomplete angiographic follow-up for 
angiographically defined restenosis (9). 
In addition to these possible explanations for our failure to 
reduce restenosis, we believe that another explanation must be 
considered. The recent study by O’Brien et al. (16) has raised 
questions as to the validity of the classical paradigm of intimal 
hyperplasia as the etiology of restenosis. Using proliferating 
cell nuclear antigen (PCNA) immunohistochemical labeling of 
human directional atherectomy specimens, these investigators 
showed that proliferation in primary and restenotic coronary 
artery lesions occurs infrequently with no obvious temporal 
peak. On the basis of experimental data from our laboratory 
and others as well as preliminary data in humans, it appears 
that differences in arterial remodeling after angioplasty, as 
measured m changes in total vessel area or area circumscribed 
by the internal elastic lamina, has a more significant impact on 
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chronic hamen diameter after angioplasty than differences in 
intimal formation. Thus, rather than considering restenosis a 
process of neointimal formation in response to balloon injury, 
these studies suggest that restenosis is a process of arterial 
remodeling in response to balloon mjury and neointimal 
formation,. Arterial remodeling may consist of compensatory 
enlargement with an increase in total vessel cross-sectional 
area, or constriction with a decrease in totzl vessel area. This 
editorial review discusses the background of arterial remodel- 
ing, reviews the preliminary evidence that it occurs after 
angioplassy in animal models and humans, shows the magni- 
tude of the effect and discusses possible mechanisms. 
Arterial Remoding in De Novo 
Atherosclerosis 
Arterial remodeling is well described in de novo atheroscie- 
rosis. Glagov et al. (17) observed that in human necropsy 
specimens, the left main coronary artery undergoes adaptive 
vessel calargement in response to progressive pla+c expan- 
sion and maintains the lumen area until the plaque lesion 
occupies ,40% of the area circumscribed by the internal elastic 
lamina or external elastic lamina, a process they termed 
compensatory enlargement. Intravascular and epicardial ultra- 
sound studies have shown that this process is not limited to the 
left main coronary artery; individual coronary arteries undergo 
compensatory enlargement that maintains lumen area as ath- 
erosclerosis develops (l&19). Zarins et al (20) showed that the 
arterial enlargement in response to increases in intimal plaque 
varies by location, with significant segmental differences in 
compensatory enlargement in the left anterior descending 
coronary artery. Thus, arterial remodeling occurs in de novo 
coronary atherosclerosis and may limit the effect of plaque 
development on lumen narrowing. 
Arterial Remodeling After Angiopiasty 
There is increasing experimental evidence that arterial 
remodeling also occurs after angioplasty. We examined the 
quantitative histologic results from animals killed immediately 
after angioplasty in the hypercholesterolemic rabbit model and 
compared them with the same areas from animals killed 4 
weeks after the procedure, when restenosis occurs in this 
model (21). Quantitative angiography was performed to ensure 
that the acute and chronic groups were comparable in minimal 
and reference lumen diameters at the time of angioplasty as 
well as in the immediate angiographic result of angioplasty. 
The area circumscribed by the internal elastic lamina increased 
by 20% from immediately after to 4-week follow-up after 
angioplasty. The compensatory enlargement of the vessel, as 
seen in the increase in internal elastic lamina area, was able to 
accommodate nearly 60% of the neointimal formation in 
response to the balloon injury and limit lumen narrowing. 
When the chronic group was divided into restenotic a.nd 
nonrestenotic subgroups, surprisingly, the intimal areas in the 
two subgroups were virtually identica:. The difference in the 
lumen area between restenotic and nonrestenotic vessels re- 
sulted from the significantly greater internal elastic lamina area 
in the nonrestenotic subgroup. 
In both restenotic and nonrestenotic vessels, the internal 
elastic lamina area was highly correlated with intimal area. In 
t5e restenotic arteries, the slope of this correlation was ~1; 
hence, for a given increase in intimal area, there was smaller 
increase in internal elastic lamina area, suggesting inadequate 
compensatory enlargement for intimal formation in this group. 
In the nonrestenotic vessels, conversely, the slope was >l, such 
that a given increase in intimal area was associated with a 
greater increase in internal elastic lamina area, with preserva- 
tion of the lumen area. These data show that vascular remod- 
eling is able to limit the effects of intimal formation on chronic 
lumen diameter and that differences in vascular remodeling, 
not differences in intimal formation, account for restenosis in 
this model. 
Data from other laboratories have also demonstrated the 
effects of vascular remodeling. Post et al. (22,231 showed that 
in normal rabbit femoral arteries subjected to primary balloon 
injury, intimal thickening accounted for only 23% of late loss in 
angiographic lumen diameter. In normal or hypercholester- 
olemic Yucatan micropig with iliac lesions induced by balloon 
deendothelialization, these investigators found that intimal 
thickening following subsequent balloon angioplasty ac- 
counted for only 11% or 49%, respectively, of the late lumen 
loss, and the major contribution to late loss was chronic 
constriction. Lafont et al. (24) have recently shown in an 
atherosclerotic rabbit femoral artery model that at the time of 
restenosis there was only a 33% increase in intimal plus medial 
area but a 52% reduction in lumen ar?a compared with the 
reference site as a result of a reduction in internal elastic 
lamina area at the lesion site. 
There is also preliminary intracoronary ultrasound evidence 
that clascular remodeling occurs after angioplasty in humans. 
Kovach et al. (25) showed that intimal format:Jn accounted for 
only 32% of late lumen loss and that a mean 7.5% decrease in 
total vesel area (corresponding to external elastic lamina 
ar;::) V:X more important. These findir?:s were confirmed in a 
larger series of patients by the same investigators (26), where 
arterial remodeling with constriction accounted for 60% of late 
lumen loss. 
Potential Magnitvde of Hfect of Arterial 
Remodeling 
The magnitude of the etiect of vascular remodeling on 
restenosis is potentially great. To il!ustrate this, the following 
derivation shows the relation, assuming a circular lumen, 
between chronic radfiJs in an artery without compensation 
(rNC) and one with compensatory enlargement (rc). If no 
compensatory enlargement occurs, the lumen area would be 
nrNC2, and plaque area in the noncompensated artery would 
be defined by the area circumscribed by the internal elastic 
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Figure 1. Expanded paradigm of resteno- 
sis after angioplasty. Several possible re- 
sponses to balloon injury are illustrated. 
The clcssical paradigm (a) is intimal for- 
mation with no remodeling. if vascular 
constriction occurs (b), even minimal 
amounts of neointima may result in resten- 
osis. A moderate amount of compensatory 
enlargement (c) may accommodate neo- 
intima with less lumen narrowing. Aug- 
mented compensatory enlargemect cd) 
may result in a widely patent artery de- 
spite significant intimal formation. IEL = 
internal elastic le:nina; PTCA = percuta- 
neous transluminal coronary angioplasty. 
w Lumen 
lamina minus the lumen area, or ?TrIEL2 - rrNC2. If one 
extrapolates the results from our animal studies, one would 
expect a 20% compensatory increase in internal elastic lamina 
area, or a 10% increase in internal elastic lamina radius 
(Llr,,,) from immediately after angioplasty to the time of 
restenosis. Thus, in an artery with compensatory enlargement, 
plaque area would be n( 1 .lrnJ2 - rrC2. If the same amount 
of intimal formation occurs in arteries with and without 
compensatory enlargement, rrlEL2 -- 7TrNC 2 = 7r(l.lr,,,)* - 
rrC2. Solving this equation for the compensated lumen radius 
gives rC2 = rNC2 + 0.21rIEL2, or rc = (rNC2 + 0.21rIEL2)1’2. 
If this equation is applied in a human coronary artery of 
3-mm reference diameter, and the reference segment has no 
intimal plaque, then lumen area is the same as the area 
circumscribed by the internal elastic lamina (rrIEL2), so rlEL = 
1.5 mm. If there is a 75% angiographic stenosis at the lesion 
and no change in the reference at follow-up in an artery with 
no compensatory enlargement, rNC = 0.375 mm. From the 
equation derived in the previous paragraph, the radius of an 
artery subjected to the same degree of injury that did undergo 
compensatory enlargement can be calculated: rc = [0.375’ + 
0.21(1.5”)]“*, or rc = 0.78 mm. Thus, a 19% compensatory 
increase in internal elastic lamina radius at the lesion site 
increases the chronic lumen radius from 0.375 to 0.78 mm, of 
a 108% increase in final lumen diameter. Similar calculations 
can be performed showing the magnitude of the effect of 
vascular constriction on final lumen diameter. It is only in 
arteries with significant stenoses that the large effects of 
vascular remodeling are apparent. 
Mechanisms of Arterial Remodeling 
A number of possible mechanisms of arterial remodeling 
have been proposed for de novo atherosclerosis. Increased 
flow with a concomitant increase in shear stress may lead to 
adaptive enlargement in nonatherosclerotic arteries, as is seen 
in arteriovenous fistulae (27,28). In stenotic arteries, increased 
shear stress at the lesion site because of increased velocity of 
flow could initiate compensatory enlargement (28-31). An- 
other possibility is that as atherosclerotic plaque develops, it may 
destroy or compress the underlying vascular supply of the artery 
anr’ damage the extracellular matrix support structure, with 
protrusion of the lesion outside the original contour of the artery 
(32), which has been described in pathologic specimens (33,34). 
The mechanism of arterial remodeling after balloon injury 
remains to be determined. After balloon angioplasty in the 
atherosclerotic rabbit model, as in humans, dissections extend- 
ing into the intima and media are common (35). These 
dissections may weaken segments of the arterial wail and allow 
enlargement in response to increased shear stress as intimal 
formation occurs. Alternatively, the inflammatory response to 
balloon in& could initiate the remodeling process through 
the release of proteolytic enzymes. Thus, either of the mech- 
anisms described above for remodeling in de ncvo atheroscle- 
rosis may occur in restenosis. If only chronic constriction were 
seen Jftcr angioplasty, one would also have to consider other 
possible etiologies, such as elastic recoil or vessel spasm. The 
fact that internal elastic lamina area increased in both rest- 
enotic and nonrestenotic arteries, compared with arteries 
examined immediately after angioplasty in the atherosclerotic 
rabbit model (21), suggests that at least in this model it is a true 
process of arterial remodeling rather than recoil or spasm. 
If the analogy of wound healing applies to vascular injury, 
one might expect a similar sequence of events: initial nonspe- 
cific inflammation followed by specific degradation of the 
preexisting collagen matrix by increased collagenase activity; 
extracellular fibronectin deposition, activated cell invasion, 
type III collagen deposition, increased type I collagen deposi- 
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tion, and finally, typical cross-linked collagen fiber appearance 
(3,36-39). Arterial remodeling may occur during this process 
of degrading preexisting matrix and depositing new matrix 
components. Concomitant with collagen deposition in gener- 
alized wound healing, the phenomenon of wound contracture 
occurs. The end result of wound contraction is to reduce the 
size of the granulation tissue volume by reorganizing the 
collagen fibrils (40). This phenomenon in the vessel wall could 
result in chronic constriction. 
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We believe that restcnosis after angioplasty can best be 
thought of as a balance between intimal formation and arterial 
remodeling (Fig. I), not intimal formation alone as in the 
current paradigm. The studies of Post et al. (22,23) and LaFont 
et al. (24) as well as the human ultrasound experience (25,26) 
suggest that in some cases actual arterial coustriction may 
occur, which, with or without intimal formation, may result in 
restenosis. In the rabbit iliac model (21), compensatory arterial 
enlargement occurred after angioplasty and limited the effect 
of intimdl formation on lumen narrowing; restenotic arteries 
had less arterial enlargement than nonrestenotic arteries. 
Compensatory enlargement and chronic constriction may rep- 
resent two ends of the spectru,m of arterial remodeling in 
response to balloon angioplasty. This expanded paradigm of 
arterial remodeling and intimal formation may in part account 
for the paucity of success in clinical trials to date, and 
therapeutic strategies to alter arterial remodeling in conjunc- 
tion with altering intimal formation may be required to reduce 
restenosis after coronary interventioas. 
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